# Ozette Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ozette-technologies

- Industry: Biotechnology
- Headquarters: Seattle, US
- Website: www.ozette.ai
- Total disclosed funding: $32M
- Latest round: Series A (Jul 28, 2022)
- Investors on record: 8

## About

Ozette Technologies, Inc. is a US-based firm specializing in advanced AI-driven computational analysis solutions for cytometry and immune data analysis, enhancing research capabilities in the biomedical field.Ozette Technologies, Inc. offers AI-driven solutions designed for cytometry and immune data analysis. The company was co-founded by Ali Ansary, Greg Finak, and Raphael Gottardo. Its headquarters are located in Seattle, US. In July 2022, Ozette raised USD 26 mn in a Series A funding round, led by Madrona Venture Group, which contributed to the total amount raised of USD 26 mn and valued the company at approximately USD 95.276 mn.Ozette Technologies specializes in advanced AI-driven computational analysis solutions tailored for cytometry and immune data analysis. Their cloud-native analysis platform processes spectral and conventional cytometry data efficiently, enabling researchers to derive insights from complex immune data. The platform is utilized by pharmaceutical companies and academic institutions in North America and Europe, focusing on targeted therapies related to patients' immune cells. Collaborative partnerships enhance their impact on scientific innovation.Ozette Technologies generates revenue through B2B transactions with pharmaceutical and academic organizations via the sale of its AI-driven analysis platform and associated services. Their revenue model is based on subscription options and service agreements, allowing for tailored solutions that align with the needs of clients in research and clinical development.In July 2022, Ozette Technologies, Inc. raised USD 26 mn, led by Madrona Venture Group, to enhance its capabilities across a multiomic platform by integrating single-cell proteomics and transcriptomics. The funding will support the development of new products and the expansion into diverse geographic markets, focusing on enhancing its platform offerings to better serve clients in biomedical research.

## Funding rounds

- Series A, Jul 28, 2022, $26M — Alexandria Venture Investments, Madrona Venture Group, Duke University, M12, OCV Partners, Cercano Management
- Seed, Feb 2, 2021, $5.8M — Madrona Venture Group, Vulcan, Allen Institute for Artificial Intelligence

## Investors

- Madrona Venture Group (https://capitalatlas.ai/funds/madrona-venture-group) — Seed, Series A
- Vulcan (https://capitalatlas.ai/funds/vulcan) — Seed
- Allen Institute for Artificial Intelligence — Seed
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series A
- Duke University — Series A
- M12 (https://capitalatlas.ai/funds/m12) — Series A
- OCV Partners (https://capitalatlas.ai/funds/ocv-partners) — Series A
- Cercano Management (https://capitalatlas.ai/funds/cercano-management) — Series A